| Recruiting | Investigation of Impact of AI on Prostate Cancer Workflow NCT07084779 | Case Comprehensive Cancer Center | N/A |
| Recruiting | PSMA PET Combined With MRI for the Detection of PCa NCT07052214 | Telix Pharmaceuticals (Innovations) Pty Limited | Phase 3 |
| Active Not Recruiting | Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness NCT05968144 | University of Maryland, Baltimore | Phase 1 / Phase 2 |
| Active Not Recruiting | A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive C NCT05849298 | Novartis Pharmaceuticals | Phase 2 |
| Recruiting | Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progr NCT06292897 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Recruiting | DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/ NCT05786716 | Cancer Research UK | Phase 2 / Phase 3 |
| Recruiting | Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression. NCT06046131 | Centre Hospitalier Universitaire de la Guadeloupe | N/A |
| Unknown | Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP NCT05667636 | Regina Elena Cancer Institute | Phase 2 |
| Unknown | A Study on Drug-drug Interactions in Patients Treated With Anticancer Agents for a Prostate Cancer in Real Lif NCT05612841 | Centre Hospitalier Universitaire de Besancon | — |
| Recruiting | Impact of Augmented Reality During Robot-assisted Radical Prostatectomy NCT06059859 | European Institute of Oncology | N/A |
| Completed | EBRT + Lu-PSMA for N1M0 Prostate Cancer NCT05162573 | The Netherlands Cancer Institute | Phase 1 |
| Unknown | 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical NCT04831307 | British Columbia Cancer Agency | N/A |
| Completed | Urinary and Prostate Microbiotes and Prostate Cancer NCT03947515 | Centre Hospitalier Universitaire de Nice | N/A |
| Active Not Recruiting | [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer NCT04484701 | British Columbia Cancer Agency | — |
| Unknown | SLPI for Prostate Cancer NCT04854343 | University of Florence | — |
| Terminated | Trial of NanoPac Focal Therapy for Prostate Cancer NCT04221828 | NanOlogy, LLC | Phase 2 |
| Completed | Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors NCT03935282 | Wake Forest University Health Sciences | N/A |
| Unknown | Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk NCT04462926 | Azienda Ospedaliero-Universitaria di Modena | N/A |
| Completed | The Effects of Method of Anaesthesia on the Safety and Effectiveness of Radical Retropubic Prostatectomy NCT05566405 | Sismanoglio General Hospital | N/A |
| Terminated | Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy NCT04234399 | University of Vermont | — |
| Completed | EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression NCT04266431 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Recruiting | Prostate Cancer Genetic Risk Evaluation and Screening Study NCT05129605 | Massachusetts General Hospital | — |
| Terminated | Organoids From Metastases of Prostate Cancer NCT03952793 | Centre Antoine Lacassagne | N/A |
| Completed | MSG Use With 18F-DCFPyL PET/CT Imaging NCT03693742 | British Columbia Cancer Agency | N/A |
| Completed | Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate Cancer NCT03982095 | Azienda USL Reggio Emilia - IRCCS | — |
| Unknown | HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-ris NCT04523896 | David Büchser | Phase 2 |
| Completed | I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW). NCT03939689 | Progenics Pharmaceuticals, Inc. | Phase 2 |
| Unknown | The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients. NCT04774133 | Regina Elena Cancer Institute | N/A |
| Completed | Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit NCT03183544 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Phase 1 |
| Completed | Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors NCT03343093 | University of Minnesota | N/A |
| Completed | Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy NCT03253744 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | 177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer NCT03490838 | Advanced Accelerator Applications | Phase 1 |
| Completed | Comparison of Multi-parametric and Bi-parametric Magnetic Resonance Imaging in Men With Suspicion of Prostate NCT03693703 | Fondazione del Piemonte per l'Oncologia | N/A |
| Completed | Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients NCT03361969 | Pantarhei Oncology B.V. | Phase 2 |
| Completed | 68Ga PSMA in Preprostatectomy Patients NCT03388346 | Michael Graham PhD, MD | Phase 2 / Phase 3 |
| Completed | 68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer NCT03389451 | Michael Graham PhD, MD | Phase 2 / Phase 3 |
| Terminated | Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biop NCT03242265 | ATGen Canada Inc | N/A |
| Completed | Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer NCT03104907 | Rigshospitalet, Denmark | N/A |
| Unknown | An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previous NCT03061643 | Samsung Medical Center | Phase 2 |
| Completed | Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study NCT02967458 | Thomas Jefferson University | Phase 2 |
| Completed | Impact of Exercise on Prognostic Biomarkers Related to Prostate Cancer NCT03397030 | The University of Texas Health Science Center at San Antonio | N/A |
| Completed | Urology of Virginia Case Series NCT03035487 | Exact Imaging | N/A |
| Completed | Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiv NCT02977143 | Seoul National University Hospital | N/A |
| Recruiting | Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castrati NCT06236789 | Yonsei University | — |
| Completed | The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep NCT02966535 | Seoul National University Hospital | N/A |
| Completed | Treatment Patterns in Metastatic Prostate Cancer NCT02729103 | Bayer | — |
| Completed | Open Anterograde Radical Prostatectomy Compared to Open Retrograde Technique NCT02687308 | Rio de Janeiro State University | N/A |
| Completed | Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical Prostatectomy NCT02526589 | Tampere University Hospital | — |
| Completed | Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Can NCT03348722 | Rete Oncologica Piemonte, Valle d'Aosta | — |
| Terminated | Carboplatin in Castration-resistant Prostate Cancer NCT02311764 | Aurelius Omlin | Phase 2 |
| Completed | Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate Biopsies NCT02971995 | Lille Catholic University | N/A |
| Completed | Detection Rate of Prostate Cancer in Men Undergoing MRI NCT04398173 | Fondazione del Piemonte per l'Oncologia | — |
| Terminated | Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Thera NCT01996696 | AHS Cancer Control Alberta | Phase 2 |
| Completed | Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer NCT01431391 | Dendreon | Phase 2 |
| Completed | IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen NCT01314118 | Janssen Biotech, Inc. | Phase 2 |
| Suspended | A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate C NCT01337518 | Enzon Pharmaceuticals, Inc. | Phase 1 |
| Completed | Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer NCT01540994 | Sharp HealthCare | N/A |
| Completed | Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve He NCT01696539 | Örebro University, Sweden | N/A |
| Completed | Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer NCT00956228 | Mayo Clinic | Phase 1 / Phase 2 |
| Completed | Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer NCT00751790 | Debiopharm International SA | Phase 3 |
| Completed | Exercise for Physical Health in Men With Prostate Cancer NCT00660686 | OHSU Knight Cancer Institute | N/A |
| Completed | Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms NCT00666926 | Verastem, Inc. | Phase 1 |
| Completed | Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial NCT00247312 | Schiffler Cancer Center | Phase 3 |
| Completed | High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implant NCT00126854 | AHS Cancer Control Alberta | N/A |
| Completed | Dietary Factors and Racial Disparities in Prostate Cancer Aggressiveness NCT03289130 | University of South Carolina | — |
| Completed | Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the NCT01081873 | Abbott | — |
| Completed | CT/MRI Co-registration Prostate Cancer NCT00252460 | University Health Network, Toronto | — |
| Completed | Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer NCT00174863 | Sanofi | Phase 2 |
| Completed | Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy NCT01316458 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Preop Conformal Radiotherapy - Prostate NCT00252447 | University Health Network, Toronto | Phase 1 / Phase 2 |
| Completed | A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer NCT00001446 | National Cancer Institute (NCI) | Phase 2 |
| Completed | A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms NCT00001444 | National Cancer Institute (NCI) | Phase 1 |
| Completed | A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma NCT00001266 | National Cancer Institute (NCI) | Phase 2 |